SALT LAKE CITY , March 20, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year ended December 31, 2023 . Recent Highlights: Announced that the Data Safety Monitoring Board (DSMB) overseeing... Read More